FDA Law Blog: Biosimilars

JULY 31, 2023

Houck — President Barack Obama signed the Comprehensive Addiction and Recovery Act of 2016 (“CARA”) intended to reverse serious prescription drug abuse trend in the United States on July 22, 2016. Three years after that letter, DEA proposed a rule to amend its regulations consistent with CARA on December 20, 2020. By Larry K.

Long-Term Care Facilities 98

Long-Term Care Facilities Pharmacy Regulations Drugs 98

FDA Law Blog: Biosimilars

AUGUST 8, 2024

Governors, state cannabis regulators, law enforcement groups and local governments weighed in, as did marijuana advocates and opponents, marijuana industry associations, Members of Congress, federal law enforcement groups, healthcare and human rights groups, unions and trade associations, and private individuals. 21 U.S.C. § 812(c)(c)(10).

Regulations 59

Regulations Pharmacy Licensing Licensing 59

Agency IQ

JULY 22, 2024

The 103 regulations the EPA is currently working on On July 5, 2024, the EPA published its Spring 2024 Unified Agenda, which reveals what regulations the agency is planning on releasing by the end of the year and beyond.

Regulations 40

Regulations Production Engineering International 40

Drug Target Review

SEPTEMBER 25, 2024

BRAF and downstream mitogen-activated extracellular signal-regulated kinase (MEK) inhibitors are combined to treat BRAF-mutated melanoma, for example. Inhibiting KDM5A, a regulator of cell proliferation, poses another interesting approach. 2016 Jul 1 [cited 2024 Sep 4];12(7):531–8. Available from: [link] 10.Vinogradova

Small Molecule 105

Small Molecule Therapies Regulations Treatment 105

Agency IQ

MAY 28, 2024

Updates to TSCA new chemicals regulations hit OIRA for review The Office of Information and Regulatory Affairs has begun review of a final rule that will change how the EPA handles new chemical reviews under the Toxic Substances Control Act (TSCA). TSCA itself has numerous subsections focused on different aspects of chemical regulation.

Regulations 40

Regulations Government Marketing Research 40

Agency IQ

SEPTEMBER 15, 2023

PFAS regulation in California (late 2023 edition) California consistently maintains its status as both one of the most important economies in the world as well as one of the most regulated states in the United States. In 2019, the state began to significantly ramp up its PFAS regulation and research.

Regulations 40

Regulations Packaging Production Organic Chemistry 40

Drug Target Review

JULY 4, 2023

The drivers behind the demand for ADCs Providing more targeted therapeutic options in the oncology space has underpinned the rapid growth of the ADC market; between 2016 to 2020, the US ADC market grew by 45 percent to a value of nearly $1.5 Antibody drug conjugated with cytotoxic payload.

Small Molecule 145

Small Molecule Drugs Clinical Pharmacology Trials 145

Advarra

DECEMBER 1, 2022

In the past several years, Health and Human Services (HHS) Office of Human Research Protections (OHRP), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH) have announced and/or implemented new regulations to address the challenges of conducting clinical trials involving multiple research sites. An Age of sIRB.

Regulations 52

Regulations Compliance FDA Clinical Trials 52

The Pharma Data

MAY 2, 2023

African Parliamentarians rally to boost life-saving laws, regulations on road safety Parliamentarians, policy-makers and experts from 10 African countries met today to strengthen laws and actions to curb the scourge of road crash deaths. Source link: [link]

Regulations 40

Regulations Government Drugs 40

FDA Law Blog: Biosimilars

NOVEMBER 1, 2023

Lenz, Principal Medical Device Regulation Expert & Sophia R. Gibbs — For more than three decades, FDA has claimed that the Federal Food, Drug & Cosmetic (FD&C Act) gives the agency legal authority to regulate laboratory developed tests (LDTs) as medical devices (see our prior post here ). Gaulkin & Jeffrey N.

Laboratories 81

Laboratories FDA Regulations Licensing 81

Agency IQ

JUNE 16, 2023

The 51 regulations that FDA is currently working on The FDA today unveiled its much-anticipated Spring 2023 Unified Agenda, a document outlining the regulations the agency plans to release in 2023 and beyond. The anticipated date of publication is June 2023, meaning we should see this regulation imminently.

Regulations 40

Regulations FDA Science Production 40

FDA Law Blog: Biosimilars

FEBRUARY 21, 2024

By Véronique Li, Senior Medical Device Regulation Expert & Ana Loloei & Allyson B. Mullen — More than five years after FDA first announced its plan to harmonize 21 CFR Part 820 with ISO 13485, on February 2, 2024, FDA finally issued the Quality Management System Regulation (QMSR) Final Rule. The new § 820.10

FDA 59

FDA Regulations Packaging Compliance 59

FDA Law Blog: Biosimilars

JANUARY 15, 2024

Let’s just say, the smackdown—er, decision—eviscerates FDA’s approach to regulating flavored e-cigarettes. Says the Court: “It is perhaps possible that FDA did its part to give the regulated community clear guidance and that one million out of one million not only got it wrong but got it unreasonably wrong. FDA failed on each count.

FDA 115

FDA Production Marketing Regulations 115

FDA Law Blog: Biosimilars

JANUARY 18, 2024

FDA conducted the eight-factor scheduling analysis required by the CSA in 2016 and found that marijuana continued to meet the scheduling criteria for remaining in schedule I. 12, 2016); Denial of Petition to Initiate Proceedings to Reschedule Marijuana, 81 Fed. Denial of Petition to Initiate Proceedings to Reschedule Marijuana, 81 Fed.

FDA 69

FDA FDA Approval Treatment Drugs 69

Agency IQ

APRIL 12, 2024

Landscape analysis: A look at the regulation of decentralized trials and what’s coming soon In the past few years, regulators and researchers have shown increased interest in leveraging decentralized trial methods – especially following the pandemic. In early 2023, AgencyIQ conducted a landscape analysis of DCT policy in the U.S.

Regulations 40

Regulations Trials Clinical Trials Science 40

The Pharma Data

DECEMBER 15, 2020

Our combined experience cuts across most industries with a specialization in US FDA Quality System Regulations and ISO 13485:2016 Quality Management System Requirements. # # #. We facilitate major change management initiatives, resolve project team limitations, and extend our clients reach through our network and experience.

Science 52

Science Compliance Regulations FDA 52

Eye on FDA

OCTOBER 19, 2022

Tik Tok was first released in 2016. FDA’s OPDP began considering an approach to regulating social media long before Tik Tok came into being. Studying DTC on broadcast television isn’t going to get us there and an approach to regulating promotional speech in social media is increasingly not platform agnostic.

FDA 89

FDA Regulations Research Production 89

FDA Law Blog: Biosimilars

MAY 22, 2023

The California Department of Food and Agriculture (CDFA) issued regulations implementing Proposition 12 on September 1, 2022, but their implementation was enjoined until July 1, 2023, pending the Supreme Court’s decision. Our focus is on the decision’s practical impact, which could be felt almost immediately.

Regulations 45

Regulations 45

FDA Law Blog: Biosimilars

APRIL 25, 2023

Note that section 3060(a) of the 21st Century Cures Act in 2016 amended section 520 of the FD&C Act and removed certain software functions from the statutory definition of a medical device. Section 524B(b)(4) of the FD&C Act authorizes FDA to issue regulations with additional requirements for cyber devices. What’s next?

FDA 105

FDA Regulations Production Drugs 105

Drug Target Review

SEPTEMBER 26, 2023

Ther Innov Regul Sci. 2016 Sep 1;81:15–20. 2016 Jan 15;96:253–73. Regul Toxicol Pharmacol RTP. Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting. 2018;53(4):519–25. J Pharmacol Toxicol Methods. Toxicol In Vitro.

Drugs 111

Drugs FDA Disease Animal Testing 111

NIH Director's Blog: Drug Development

FEBRUARY 27, 2018

In an analysis of more than 28 million papers in the PubMed.gov database , researchers found NIH contributed to published research that was associated with every single one of the 210 new drugs approved by the Food and Drug Administration from 2010 through 2016 [1]. Reference: [1] Contribution of NIH funding to new drug approvals 2010-2016.

Research 52

Research Science FDA Pharmaceutical Companies 52

National Institute on Drug Abuse: Nora's Blog

SEPTEMBER 25, 2024

Great progress has been made in reducing smoking in the United States, which has led to major improvements in health, but the rapidly growing vaping industry, if not properly regulated, could jeopardize this. Published March 21, 2016. Prevalence of Problem Gambling: A Meta-analysis of Recent Empirical Research (2016–2022).

Drugs 106

Drugs Production Science Marketing 106

Agency IQ

MAY 26, 2023

EPA proposes amendments to TSCA new chemicals and to remove exemptions for PFAS and PBTs EPA has proposed long-awaited amendments to the Toxic Substances Control Act (TSCA) review of new chemicals to codify practices in keeping with the 2016 TSCA amendments.

Regulations 40

Regulations 40

FDA Law Blog: Biosimilars

JANUARY 18, 2024

The company asserts that carbadox residues fall below dangerous levels before the products hit consumers’ plates, and that the Agency’s anti-carbadox bias and failure to follow the mandated regulatory procedures violated the “the FDCA, FDA’s regulations, the APA, and due process.” Carbadox has had a tortured approval history.

FDA 59

FDA FDA Approval International Production 59

Common Sense for Drug Policy Blog

JUNE 6, 2024

2015 ), with raw powders imported from ‘producer’ countries like China, Egypt, Greece, Thailand, Turkey, and India (Antonopoulos and Hall 2016 ; Brennan et al. As a result, the authors describe the online IPED market as ‘decentralized, highly flexible with no hierarchies, and open to anyone’ (Antonopoulos and Hall 2016 : 708).

Marketing 40

Marketing Drugs Production Pharmaceuticals 40

Broad Institute

AUGUST 31, 2023

Through the imposition of a user-defined GRN in its architecture, GRouNdGAN simulates steady-state and transient-state single-cell datasets where genes are causally expressed under the control of their regulating transcription factors (TFs).

RNA 40

RNA Regulations 40

Advarra

JULY 21, 2022

When the human subject protection regulations were originally established, clinical trials primarily took place at academic institutions. In 2016, National Institutes of Health (NIH) announced its Single IRB Policy , requiring domestic awardees and domestic sites conducting NIH-funded multisite research to move to a single IRB of record.

Compliance 52

Compliance Clinical Trials International Trials 52

Advarra

DECEMBER 15, 2022

Policies and Regulations Affecting Single IRB Review. Established in December 2016, this act included a requirement for the FDA to harmonize with other U.S. Health and Human Services (HHS) regulations as much as practicable, which includes sIRB requirements. Working with an sIRB remains completely voluntary in many cases.

Clinical Trials 52

Clinical Trials Regulations FDA Trials 52

The Pharma Data

NOVEMBER 11, 2020

For this study, Vu and her team looked at more than 1,400 people who vaped in 2016. Food and Drug Administration has announced plans to step up regulation of e-cigarettes. “There should be much closer regulation of what type of devices are allowed to be on the market,” said Bhatnagar, who wasn’t part of the study.

Regulations 52

Regulations Production Research Science 52

NIH Director's Blog: Drug Discovery

MAY 9, 2019

If successful, such efforts could revolutionize biology by helping us better understand how allosteric proteins reconfigure themselves in the right shapes at the right times to regulate cell signaling, metabolism, and many other important biological processes. 2016 Feb;13(2):177-183. 2016 Jun 2;12(6):e1004966. Nat Methods.

Engineering 52

Engineering Regulations Science Therapies 52

Policy Prescription

JANUARY 31, 2022

state boards of pharmacy to properly regulate pharmacies that irresponsibly and too often illegally profited from opioid drug sales to patients. From the Commonwealth Fund : “West Virginia had not only the highest state rate of “deaths of despair” in 2016 but the biggest increase in deaths from these causes since 2005.”.

Pharmacy 52

Pharmacy Regulations Doctors Drugs 52

Agency IQ

MAY 26, 2023

EPA proposes amendments to TSCA new chemicals and to remove exemptions for PFAS and PBTs EPA has proposed long-awaited amendments to the Toxic Substances Control Act (TSCA) review of new chemicals to codify practices in keeping with the 2016 TSCA amendments. MAY 21, 2023 1:17 PM CDT Regulatory background On June 22, 2016, the “Frank R.

Regulations 40

Regulations Engineering Production Government 40

New Drug Approvals

SEPTEMBER 29, 2024

At CTAD, the company announced plans for a confirmatory trial, pending discussions with regulators. All were deemed unrelated to drug. There was no evidence of ARIA or other imaging abnormalities. The plan was to test atuzaginstat in people with mild to moderate AD and evidence of P. Examples Example 1. mmol, 1.00 mmol, 7.38 mmol, 8.82

Small Molecule 62

Small Molecule DNA Disease Trials 62

Drug Target Review

SEPTEMBER 4, 2023

2018): Silent Information Regulator 2 from Trypanosoma cruzi is a potential target to infection control, IntechOpen. 2016): The trypanosome alternative oxidase: a potential drug target? 2018): Insights into antitrypanosomal drug mode-of action from cytology-based profiling, PLOS Neglected Tropical disease. 12(11): e0006980. Nilmar, S.

Drugs 111

Drugs RNA DNA Disease 111

Advarra

NOVEMBER 17, 2022

In 2016, the Food and Drug Administration (FDA) approved Spinraza (nusinersen). The regulations at 21 CFR part 50, subpart D summarize the additional safeguards for children in clinical investigations. 1] FDA’s regulations at 21 CFR 50.3(o) 2] FDA’s regulations define the term Clinical Investigation at 21 CFR 50.3(c).

Clinical Trials 52

Clinical Trials Trials FDA Clinical Research 52

Broad Institute

JUNE 14, 2023

was named president and CEO of Dana-Farber Cancer Institute in 2016. A trailblazer in cancer research, Glimcher's research identified key transcriptional regulators of protective immunity and the origin of pathophysiologic immune responses underlying autoimmune, infectious, and malignant diseases. Glimcher, M.D.,

Medical Schools 52

Medical Schools Immune Response Science Hospitals 52

Agency IQ

AUGUST 30, 2024

FDA AdComm to discuss patient-centric informed consent The FDA’s Center for Devices and Radiological Health (CDRH) will soon convene its Patient Engagement Advisory Committee to discuss “patient-centered informed consent” policies – notably, not just for medical devices but for “FDA regulated medical products” writ large.

FDA 40

FDA Regulations Clinical Trials Production 40